Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Shareholders' Equity (Deficit)

v3.24.1
Consolidated Statements of Changes in Shareholders' Equity (Deficit) - GBP (£)
Common Stock [Member]
Deferred Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2021 £ 195,476 £ 16,710,757 £ (33,465,282) £ (16,559,049)
Balance, shares at Dec. 31, 2021 390,952      
Share-based compensation expense 1,123,250 1,123,250
Issuance of ordinary shares, net of issuance costs £ 202,017 16,597,811 16,799,828
Balance, shares 559,006      
Redesignation of nominal value to deferred shares £ (397,398) £ 397,398
Balance, shares 794,955      
Adjustments to convert from IFRS to GAAP 280,837 280,837
Net loss (1,313,601) (1,313,601)
Balance at Dec. 31, 2022 £ 95 £ 397,398 33,308,568 (33,374,796) 331,265
Balance, shares at Dec. 31, 2022 949,958 794,955      
Share-based compensation expense 444,459 444,459
Issuance of ordinary shares, net of issuance costs £ 1,962 5,231,151 5,233,113
Balance, shares 19,620,130      
Net loss (5,906,953) (5,906,953)
Reclassification of warrants to equity 1,550,367 1,550,367
Issuance of warrants 1,032,979 1,032,979
Balance at Dec. 31, 2023 £ 2,057 £ 397,398 £ 41,123,065 £ (38,837,290) £ 2,685,230
Balance, shares at Dec. 31, 2023 20,570,088 794,955